Bioavailability of Voriconazole

Status Withdrawn

Clinical Trial Summary

The objective of this study is to obtain the absolute bioavailability of voriconazole in critically ill ICU patients, because pharmacokinetics can be different in critically ill patients due to alterations in function of various organs and body systems compared with healthy volunteers.

Clinical Trial Description

The bioavailability of voriconazole, based on healthy volunteers, is estimated to be >90%. Due to the high bioavailability of voriconazole, switching between oral and intravenous administration is permitted if clinically allowed. Few data are available for the bioavailability of voriconazole in critically ill patients. However, to obtain a therapeutic concentration of voriconazole (>1.5 mg/L, which is associated with a beneficial response to treatment) one study showed that a higher oral dose is required compared with the intravenous dose, to obtain this therapeutic concentration. Therefore, the pharmacokinetics can be changed in critically ill patients, including bioavailability.

In this study, patients who receive voriconazole orally (prescribed by their attending physician) will receive one intravenous dose of voriconazole instead of the oral dose. The intravenous dose will be the same as the oral dose voriconazole. ;

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02110316
Study type	Interventional
Source	University Medical Center Groningen
Contact
Status	Withdrawn
Phase	Phase 4
Start date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05539521` - Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation	Phase 2
Recruiting	`NCT04776486` - Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance	N/A
Completed	`NCT05766319` - The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission	N/A
Recruiting	`NCT03231540` - The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)	N/A
Completed	`NCT02286869` - Cardioventilatory Coupling in Critically Ill Patients	N/A
Completed	`NCT01434823` - 24 Hour Intensivist Coverage in the Medical Intensive Care Unit	N/A
Active, not recruiting	`NCT01142570` - Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients	N/A
Completed	`NCT01167595` - Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients	N/A
Completed	`NCT01293708` - Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Not yet recruiting	`NCT00916591` - Prokinetic Drugs and Enteral Nutrition	N/A
Recruiting	`NCT00654797` - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2	Phase 2
Withdrawn	`NCT00178321` - Improving Sleep in the Pediatric Intensive Care Unit	N/A
Completed	`NCT01168128` - PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study	N/A
Completed	`NCT02447692` - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study	N/A
Recruiting	`NCT04582760` - Early Mobilization in Ventilated sEpsis & Acute Respiratory Failure Study	N/A
Not yet recruiting	`NCT05961631` - Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation
Completed	`NCT03276650` - Admission of Adult-onset Still Disease Patients in the ICU
Completed	`NCT03922113` - Muscle Function After Intensive Care
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT06027008` - Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults	N/A